CCT
GSK icon

Country Club Trust’s GSK GSK Stock Holding History

Country Club Trust’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$369K Buy
+6,691
New +$348K 0.03% 227

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Country Club Trust's GSK Position: Q4 2021 in Review

Country Club Trust opened a new position in GSK (GSK) in Q4 2021: 6,691 shares worth $369K. The stake represents 0.03% of the portfolio and ranks #227 among its holdings.

919 funds tracked by Wall St. Rank hold GSK as of Q4 2021.

  • Country Club Trust held 6,691 shares of GSK worth $369K as of Q4 2021.
  • GSK was a new Country Club Trust position in Q4 2021.
  • GSK made up 0.03% of Country Club Trust's portfolio in Q4 2021, its #227 holding.
  • 919 funds tracked by Wall St. Rank held GSK as of Q4 2021.

Based on Country Club Trust's 13F filing for Q4 2021, filed 21 Jan 2022.